Fondazione Oncologia Niguarda Onlus

Fondazione Oncologia Niguarda Onlus - organizzazione non-profit per lassistenza e la ricerca terapeutica per il malato di tumore

OVERVIEW

The website oncologianiguarda.org presently has an average traffic ranking of zero (the smaller the more users). We have inspected nineteen pages within the web page oncologianiguarda.org and found one website interfacing with oncologianiguarda.org. There is one contacts and locations for oncologianiguarda.org to help you correspond with them. There is three public networking sites retained by oncologianiguarda.org. The website oncologianiguarda.org has been online for seven hundred and twenty-seven weeks, eight days, sixteen hours, and fourteen minutes.
Pages Crawled
19
Links to this site
1
Contacts
1
Addresses
1
Social Links
3
Online Since
Mar 2011

ONCOLOGIANIGUARDA.ORG TRAFFIC

The website oncologianiguarda.org is seeing diverging amounts of traffic for the duration of the year.
Traffic for oncologianiguarda.org

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for oncologianiguarda.org

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for oncologianiguarda.org

Date Range

All time
This Year
Last Year
Last Month

ONCOLOGIANIGUARDA.ORG HISTORY

The website oncologianiguarda.org was first filed on March 24, 2011. It is now seven hundred and twenty-seven weeks, eight days, sixteen hours, and fourteen minutes old.
REGISTERED
March
2011

PERIOD

13
YEARS
11
MONTHS
5
DAYS

LINKS TO DOMAIN

WHAT DOES ONCOLOGIANIGUARDA.ORG LOOK LIKE?

Desktop Screenshot of oncologianiguarda.org Mobile Screenshot of oncologianiguarda.org Tablet Screenshot of oncologianiguarda.org

CONTACTS

Contact Privacy Inc. Customer 0136036896

Contact Privacy Inc. Customer 0136036896

96 Mowat Ave

Toronto, ON, M6K3M1

CA

ONCOLOGIANIGUARDA.ORG SERVER

I caught that a lone page on oncologianiguarda.org took one thousand seven hundred and fifty milliseconds to stream. Our web crawlers could not discover a SSL certificate, so in conclusion our crawlers consider this site not secure.
Load time
1.75 secs
SSL
NOT SECURE
Internet Protocol
62.149.142.177

NAME SERVERS

dns2.technorail.com
dns.technorail.com
dns3.arubadns.net
dns4.arubadns.cz

SERVER OS

We identified that oncologianiguarda.org is employing the Apache operating system.

HTML TITLE

Fondazione Oncologia Niguarda Onlus

DESCRIPTION

Fondazione Oncologia Niguarda Onlus - organizzazione non-profit per lassistenza e la ricerca terapeutica per il malato di tumore

PARSED CONTENT

The website has the following on the site, "La Fondazione Oncologia Niguarda Onlus di Milano ha aperto la selezione di un Assistente Amministrativo." We analyzed that the web page also said " Un saluto a Getulio Alviani." It also stated " Un saluto a Getulio Alviani. Benefattore e amico grande è morto e lascia un vuoto tanto grande quanto la sua immensa generosità di persona unica. Onlus dellOspedale Niguarda di Milano per ricerca, borse di studio e accoglienza. NON COSTA NULLA! Fondata nel 1975, la European ." The header had Fondazione Oncologia Niguarda Onlus as the highest ranking search term.

SEEK OTHER WEB PAGES

Oncologiaortopedica.com Juan David Valencia H. Ortopedista Oncólogo

Siempre estamos dispuestos a resolver sus inquietudes, escribanos y nos estaremos comunicando con usted. Necesitamos verificar que eres humano.

Oncologia Pediatrica - Home

Terapie personalizzate e nuovi farmaci per la cura dei tumori infantili. Per superare tali ostacoli nel 2007 è stata promulgata una legge volta ad incoraggiare le Industrie Farmaceutiche ad effettuare studi in Pediatria. La legge concede un incentivo economico per le aziende farmaceutiche che sperimentano un farmaco nei pazienti pediatrici attraverso un prolungamento del brevetto relativo al nuovo farmaco.

Oncología Personalizada

Espacio para intercambio de opiniones, comentarios, novedades y bibliografía sobre Oncología. Dirigido a profesionales de la Salud y estudiantes. Domingo, 2 de noviembre de 2014. Interacciones farmacológicas riesgosas en pacientes con cáncer. Así como los inhibidores de la monoamino-oxidasa.